Farr Miller & Washington’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $2.51M | Buy |
3,364
+267
| +9% | +$199K | 0.16% | 62 |
|
|
2021
Q2 | $2M | Buy |
3,097
+290
| +10% | +$187K | 0.13% | 67 |
|
|
2021
Q1 | $1.6M | Buy |
2,807
+80
| +3% | +$45.7K | 0.11% | 77 |
|
|
2020
Q4 | $1.59M | Buy |
2,727
+105
| +4% | +$61.2K | 0.12% | 67 |
|
|
2020
Q3 | $1.35M | Buy |
2,622
+123
| +5% | +$63.4K | 0.12% | 69 |
|
|
2020
Q2 | $1.13M | Sell |
2,499
-65
| -3% | -$29.3K | 0.09% | 74 |
|
|
2020
Q1 | $899K | Buy |
2,564
+67
| +3% | +$23.5K | 0.08% | 70 |
|
|
2019
Q4 | $924K | Buy |
2,497
+261
| +12% | +$96.6K | 0.07% | 77 |
|
|
2019
Q3 | $744K | Buy |
2,236
+311
| +16% | +$103K | 0.06% | 87 |
|
|
2019
Q2 | $602K | Buy |
1,925
+54
| +3% | +$16.9K | 0.05% | 92 |
|
|
2019
Q1 | $572K | Hold |
1,871
| – | – | 0.05% | 88 |
|
|
2018
Q4 | $434K | Buy |
1,871
+50
| +3% | +$11.6K | 0.04% | 94 |
|
|
2018
Q3 | $570K | Buy |
1,821
+20
| +1% | +$6.26K | 0.05% | 92 |
|
|
2018
Q2 | $520K | Buy |
1,801
+20
| +1% | +$5.78K | 0.05% | 91 |
|
|
2018
Q1 | $445K | Buy |
1,781
+55
| +3% | +$13.7K | 0.04% | 107 |
|
|
2017
Q4 | $412K | Hold |
1,726
| – | – | 0.04% | 107 |
|
|
2017
Q3 | $384K | Buy |
1,726
+21
| +1% | +$4.67K | 0.04% | 111 |
|
|
2017
Q2 | $386K | Buy |
1,705
+680
| +66% | +$154K | 0.04% | 108 |
|
|
2017
Q1 | $204K | Buy |
+1,025
| New | +$204K | 0.02% | 144 |
|